Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 22489 | 323 | 38.0 | 87% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 232 | 19686 | TAMOXIFEN//AROMATASE INHIBITORS//ANASTROZOLE |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | ESTROGEN RECEPTOR ALPHA GENE ESR1 | Author keyword | 6 | 80% | 1% | 4 |
| 2 | ESTROGEN RECEPTOR POLYMORPHISMS | Author keyword | 5 | 63% | 2% | 5 |
| 3 | ESTROGEN RECEPTOR 1 | Author keyword | 4 | 36% | 3% | 9 |
| 4 | BIOL CELULAR MOL CANC HUMANO | Address | 2 | 67% | 1% | 2 |
| 5 | ESR1 POLYMORPHISMS | Author keyword | 2 | 67% | 1% | 2 |
| 6 | ESTROGEN RECEPTOR ALPHA GENE POLYMORPHISMS | Author keyword | 2 | 67% | 1% | 2 |
| 7 | GRP INFLAMMAT BIOL IMMUNOGENET | Address | 2 | 67% | 1% | 2 |
| 8 | XBAI | Author keyword | 2 | 29% | 2% | 6 |
| 9 | ESTROGEN RECEPTOR GENE | Author keyword | 2 | 20% | 3% | 9 |
| 10 | ESTROGEN RECEPTOR ALPHA GENE | Author keyword | 2 | 21% | 2% | 7 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ALPHA GENE POLYMORPHISMS | 7 | 33% | 5% | 17 |
| 2 | ESTROGEN RECEPTOR POLYMORPHISMS | 3 | 100% | 1% | 3 |
| 3 | ESR2 GENE | 3 | 50% | 1% | 4 |
| 4 | ESR2 | 3 | 60% | 1% | 3 |
| 5 | PVUII | 3 | 35% | 2% | 6 |
| 6 | OLDER CAUCASIAN WOMEN | 2 | 67% | 1% | 2 |
| 7 | STOOL PATTERNS | 2 | 67% | 1% | 2 |
| 8 | ANGIOGRAPHIC EXTENT | 2 | 43% | 1% | 3 |
| 9 | ESR1 GENE | 1 | 38% | 1% | 3 |
| 10 | ALPHA VARIANTS | 1 | 100% | 1% | 2 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| A review of estrogen receptor alpha gene (ESR1) polymorphisms, mood, and cognition | 2010 | 26 | 108 | 31% |
| The Association Between the rs2234693 and rs9340799 Estrogen Receptor alpha Gene Polymorphisms and Risk Factors for Cardiovascular Disease: A Review | 2010 | 8 | 70 | 47% |
| Genetic polymorphisms in the estrogen receptor-a gene and the risk of endometrial cancer: a meta-analysis | 2012 | 4 | 27 | 37% |
| A renewal in the study of political parties history | 2007 | 0 | 2 | 100% |
| Estrogen Receptor Polymorphism and Its Relationship to Pathological Process | 2010 | 4 | 64 | 50% |
| Mutations and polymorphisms of estrogens receptors genes and diseases susceptibility | 2012 | 4 | 139 | 22% |
| Estrogen associated gene polymorphisms and their interactions in the progress of Alzheimer's disease | 2013 | 5 | 199 | 14% |
| Genetic variation of estrogen metabolism and the risks of cardiovascular disease | 2007 | 7 | 41 | 41% |
| Association of estrogen receptor genes and schizophrenia: A preliminary study | 2012 | 3 | 34 | 24% |
| Polymorphism of ACE, Angiotensin II, NO-Synthase, Estrogen Receptor Genes and Gender Differences in Their Effects on Development of Cardiovascular Pathology | 2009 | 0 | 14 | 50% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | BIOL CELULAR MOL CANC HUMANO | 2 | 67% | 0.6% | 2 |
| 2 | GRP INFLAMMAT BIOL IMMUNOGENET | 2 | 67% | 0.6% | 2 |
| 3 | PREVENT MED CARDIOL | 1 | 40% | 0.6% | 2 |
| 4 | BIOL CELULAR ENVELHECIMENTO | 1 | 33% | 0.6% | 2 |
| 5 | DR CHI HSING HUANG STROKE | 1 | 50% | 0.3% | 1 |
| 6 | HEART STUDY | 1 | 50% | 0.3% | 1 |
| 7 | NEPHROGENET UNIT | 1 | 50% | 0.3% | 1 |
| 8 | NPFPC CONTRACEPT ADVERSE REACT MONITORING | 1 | 50% | 0.3% | 1 |
| 9 | PL MOL BIOL PHARMACOGEN | 1 | 50% | 0.3% | 1 |
| 10 | UNITAT PSIQUIAT | 1 | 50% | 0.3% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000207117 | CYP17//ANDROGEN RECEPTOR GENE//CAG REPEAT POLYMORPHISM |
| 2 | 0.0000192462 | MOL STAT GENET//OSTEOPROTEGERIN GENE//OSTEOPOROSIS |
| 3 | 0.0000167215 | ESTROGEN RECEPTOR BETA//ER BETA//RECEPTOR BIOL SECT |
| 4 | 0.0000163599 | ESTROGEN RECEPTOR VARIANTS//JC HEUSON CANCEROL MAMMAIRE//SERV HISTOL CYTOL EXPT |
| 5 | 0.0000130895 | SHBG GENE POLYMORPHISM//CLIN MED CHEM MED//ENDOCRINE SECT INTERNAL MED 3 |
| 6 | 0.0000111455 | HORMONE REPLACEMENT THERAPY//HORMONE THERAPY//TIMING HYPOTHESIS |
| 7 | 0.0000095732 | BIOPHYS LIFE SCI//PROJECT SPECIAL COORDINATE FUNDS PROMOTING SCI//SPINE SYNAPSE DENSITY |
| 8 | 0.0000084789 | AGE AT MENOPAUSE//AGE AT NATURAL MENOPAUSE//EARLY MENOPAUSE |
| 9 | 0.0000081692 | COMPREHENS OBES//CELLULAR MOL SPORTS MED//ARKO MOUSE |
| 10 | 0.0000074737 | ITEM FACTOR MODEL//HOSP BEHAV MED//HAPLOTYPE RELATIVE RISK HRR |